February 1, 2023
Via: PMLiVEThe antibody will now benefit from the incentives given to those drugs granted orphan status through the FDA’s ODD programme, introduced by the organisation to improve the availability of treatments for rare diseases. Affecting two to ten people per million, […]
July 11, 2024
July 11, 2024
July 19, 2024